Literature DB >> 3678638

Effect of bisacodyl on intestinal electrolyte and water net transport and transit. Perfusion studies in men.

K Ewe1.   

Abstract

The effect of bisacodyl on intestinal electrolyte, glucose, and water transport, and transit was studied in 6 healthy volunteers by intestinal perfusion. A 5-lumen tube with an occluding balloon allowed constant perfusion (10 ml/min) of 30 cm of the upper jejunum and a rapid collection of the perfusate free of contaminants. A phenol red bolus was injected into the tube and its passage through the test segment was calculated by dye dilution formula. A 1-hour control period was followed by a test period with 6 mg/h bisacodyl and followed by 2 other 1-hour control periods. Net absorption of Na+ (0.35 +/- 0.08 mmol/min) and water (1.7 +/- 0.6 ml/min) changed to net secretion (Na+ -0.93 +/- 0.3 ml/min; water -6.6 +/- 1.9 ml/min), glucose absorption decreased from 25.4% +/- 1.1 to 6.3 +/- 0.5 mg/min and K secretion was enhanced. 62 +/- 2.1% of bisacodyl was absorbed in the 30-cm jejunal segment. Mean transit time decreased from 8.5 +/- 1 to 4.4 +/- 0.7 min and mean flow rate increased from 8.4 +/- 0.6 16.6 +/- 1.9 ml/min. There was an inverse linear relationship between mean transit time and mean flow rate. All the effects of bisacodyl were fully or at least partially reversible. Volume and calculated radius of the test segment remained constant and did not change under bisacodyl. It is concluded, that the secretory effect of bisacodyl is mainly responsible for the decreased mean transit time rather than a direct effect on motility.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678638     DOI: 10.1159/000199508

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  6 in total

1.  Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults.

Authors:  Amalia Diakidou; Maria Vertzoni; Konstantinos Goumas; Erik Söderlind; Bertil Abrahamsson; Jennifer Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2009-07-02       Impact factor: 4.200

2.  Prospective evaluation of small bowel preparation with bisacodyl and sodium phosphate for capsule endoscopy.

Authors:  Andreas Franke; Frank Hummel; Phillip Knebel; Christoph Antoni; Ulrich Bocker; Manfred V Singer; Matthias Lohr
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

Review 3.  [Therapeutic options of chronic constipation].

Authors:  H Krammer; F Schlieger; M V Singer
Journal:  Internist (Berl)       Date:  2005-12       Impact factor: 0.743

4.  Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers.

Authors:  N Manabe; F Cremonini; M Camilleri; W J Sandborn; D D Burton
Journal:  Aliment Pharmacol Ther       Date:  2009-08-12       Impact factor: 8.171

5.  Spicatoside A in red Liriope platyphylla displays a laxative effect in a constipation rat model via regulating mAChRs and ER stress signaling.

Authors:  Ji Eun Kim; Jun Go; Hee Seob Lee; Jin Tae Hong; Dae Youn Hwang
Journal:  Int J Mol Med       Date:  2018-10-29       Impact factor: 4.101

Review 6.  Bisacodyl: A review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation.

Authors:  Maura Corsetti; Sabine Landes; Robert Lange
Journal:  Neurogastroenterol Motil       Date:  2021-03-09       Impact factor: 3.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.